New drug for Fentanyl Pharmaceuticals Sodium Tablets Gets FDA Approval
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
on November 27,, Haizheng Pharmaceuticals announced that its controllingcompany,(http://) andnew drug(http://) of theof sodium tablets in haizheng Pharmaceuticals (Hangzhou), has been approved by the u.SFDA(http://about theof sodium pervadin is mainly used to treat primary hypercholesterolemia that is still not controlled by dietary restrictionsThe original drug of Pfvastatin is developed by Bristol-Myers Squibb, and the domestic and foreign manufacturers are DAIICHI SANKYO, GLEN MARK PHARMA, TEVAPHARMACEUTICA, HanyuPharmaceutical(http://Co., Ltd., North China Pharmaceutical Co., Ltd according to , the global sales of the Puvastatin sodium tablets in 2017 were about $567 million, of which the U.S market was about $186 million, and in January-June 2018, global sales were about $243 million, of which the U.S market was about $67 million (data from IMS) so far, Haizheng Hangzhou has invested about RMB4.6 million in the research and development project of the Pharmaceutical (http://
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
